Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #547

    Ja, så er vi jo tilbage til hvor meget du kan bruge TA til i Biotek. !!. Som sagt er biotek jo event drevet, og derfor svært at lave TA på .

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #548

      well then let's wait for what Novartis have to say on Ofa this afternoon at their R&D update, 14:00 CET
      https://www.novartis.com/investors/event-calendar

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #549

        maybe they can break the channel 😉

        1 Reply Last reply
        0
        • Legolas23L Offline
          Legolas23L Offline
          Legolas23
          wrote on sidst redigeret af
          #550

          TA er vel mange gange fokuspunkter som for mere opmærksomhed, når det går ekstremt godt eller ekstremt skidt. Ellers ser jeg også TA som for den kortsigtede investor, men dog relevant for den kommende udvikling, da der mange gange er tale om en samlet selvforstærkende psykologi.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #551

            "Novartis is advancing a pipeline of medicines with potential to change the standard of care in high burden disease areas. In multiple sclerosis ….blablabla… Also in MS, OMB157 (ofatumumab) is a next generation B-cell depletor with a potentially favorable safety profile from faster b-cell repletion and preserved immunity, and with a convenient monthly sub-cutaneous dosing."

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #552

              (from their press release)

              1 Reply Last reply
              0
              • R Offline
                R Offline
                Raun
                wrote on sidst redigeret af
                #553

                Udstiller lige min manglende indsigt.... Jeg forstår simpelthen ikke. hvad godt der kan komme ud af at lade (i dette tilfælde) kineserne "lege" med Genmab's patenterede Duobody. Som JvdW nævnte i Aarhus?..... Tænker at hvis man sidder på en teknologi der kan blive epokegørende. Så beskytter man vel teknologien så godt som overhovedet muligt??

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Raun
                  wrote on sidst redigeret af
                  #554

                  Og det er vel ikke måden at gøre dete på!?

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #555

                    Logikken er vel, at ved at gøre det gratis vil flere gøre forsøg med Duobody. Og jo flere der gør forsøg, jo flere succeer vil der være, som ender i klinikken, og som der skal betales licens for.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #556

                      in other words; you have to trust the Chinese to respect your patent (or anybody else for that matter)

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #557

                        Det har aldrig været hensigten, at Duobody kun skulle være til intern brug. Genmab inviterer ligefrem: http://www.genmab.com/duobody/open-innovation

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #558

                          As we have seen before. ! - Chinese do NOT respect any patent. Just ask Trump. 😉

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #559

                            Han pointerede vel også, at han ikke ville overdrage cellelinierne, der producerer antistofferne.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #560

                              I found it also interesting that he said that Janssen was scared to produce in China if i heard correct?

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #561

                                Yes I belive so. Chinese are world class in copying !

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  Mohammed_Khalil
                                  wrote on sidst redigeret af
                                  #562

                                  Hvad ser i af muligheder i Genmab, hvis man tænker langsigtet? Hvad synes i om kursen lige pt. (skal man købe eller vente)?

                                  1 Reply Last reply
                                  0
                                  • nohopeN Offline
                                    nohopeN Offline
                                    nohope
                                    wrote on sidst redigeret af
                                    #563

                                    Hvis du er langsigtet skal du ikke købe ELLER vente, du skal købe OG vente.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #564

                                      lol

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #565

                                        Novartis has put their presentation at the above link . Plenty of attention to Ofa in MS!

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          lahn1
                                          wrote on sidst redigeret af
                                          #566

                                          Thank you EL!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger